Clinical trials of an experimental treatment for adults with leukemia were abruptly stalled by the Food and Drug Administration after two patients died of complications from neurotoxicity last week. Juno Therapeutics, a development-stage biotechnology company, has been experimenting with treatments that use immune cells, or T-cells, engineered to attack cancerous acute lymphoblastic leukemia cells in…

Learn More